Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication
Open Access
- 4 December 2014
- journal article
- review article
- Published by Elsevier BV in Journal of Pharmacological Sciences
- Vol. 127 (1), 6-9
- https://doi.org/10.1016/j.jphs.2014.11.010
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (24116006)
This publication has 29 references indexed in Scilit:
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depressionProgress in Neurobiology, 2013
- Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by Ifenprodil: The Role of Sigma-1 and IP3 ReceptorsPLOS ONE, 2012
- Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disordersEmerging Therapeutic Targets, 2011
- The sigma-1 receptor chaperone as an inter-organelle signaling modulatorTrends in Pharmacological Sciences, 2010
- Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: Role of sigma-1 receptorsBrain Research, 2009
- High occupancy of σ1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503International Journal of Neuropsychopharmacology, 2009
- Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling PathwaysPLOS ONE, 2008
- Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell SurvivalCell, 2007
- Phencyclidine-Induced Cognitive Deficits in Mice are Improved by Subsequent Subchronic Administration of Fluvoxamine: Role of Sigma-1 ReceptorsNeuropsychopharmacology, 2006
- Steroid Binding at σ Receptors Suggests a Link Between Endocrine, Nervous, and Immune SystemsScience, 1988